Literature DB >> 12761006

Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs.

Karl H Stadlbauer1, Horst G Wagner-Berger, Volker Wenzel, Wolfgang G Voelckel, Anette C Krismer, Günter Klima, Klaus Rheinberger, Sebastian Pechlaner, Viktoria D Mayr, Karl H Lindner.   

Abstract

UNLABELLED: We sought to determine the effects of a combination of vasopressin and epinephrine on neurologic recovery in comparison with epinephrine alone and saline placebo alone in an established porcine model of prolonged cardiopulmonary resuscitation (CPR). After 4 min of cardiac arrest, followed by 3 min of basic life support CPR, 17 animals were randomly assigned to receive, every 5 min, either a combination of vasopressin and epinephrine (vasopressin [IU/kg]/epinephrine [ micro g/kg]: 0.4/45, 0.4/45, and 0.8/45; n = 6), epinephrine alone (45, 45, and 200 micro g/kg; n = 6), or saline placebo alone (n = 5). After 22 min of cardiac arrest, including 18 min of CPR, defibrillation was attempted to achieve the return of spontaneous circulation. Aortic diastolic pressure was significantly (P < 0.01) increased 90 s after each of 3 vasopressin/epinephrine injections versus epinephrine alone versus saline placebo alone (mean +/- SEM: 69 +/- 3 mm Hg versus 45 +/- 3 mm Hg versus 29 +/- 2 mm Hg, 63 +/- 4 mm Hg versus 27 +/- 3 mm Hg versus 23 +/- 1 mm Hg, and 52 +/- 4 mm Hg versus 21 +/- 3 mm Hg versus 16 +/- 3 mm Hg, respectively). Spontaneous circulation was restored in six of six vasopressin/epinephrine pigs, whereas six of six epinephrine and five of five saline placebo pigs died (P < 0.01). Neurologic evaluation 24 h after successful resuscitation revealed only an unsteady gait and was normal 5 days after the experiment in all vasopressin/epinephrine-treated animals. In conclusion, in this porcine model of prolonged CPR, repeated vasopressin/epinephrine administration, but not epinephrine or saline placebo alone, ensured long-term survival with full neurologic recovery. IMPLICATIONS: We present a study to evaluate the effects of a combination of vasopressin and epinephrine during prolonged cardiopulmonary resuscitation on neurological outcome in pigs. We found that all pigs treated with a combination of vasopressin and epinephrine could be resuscitated and had full neurologic recovery observed over an entire period of 5 days.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761006     DOI: 10.1213/01.ane.0000066017.66951.7f

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.

Authors:  Jon B Cole; Justin N Corcoran; Kristin M Engebretsen; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2020-01-24

2.  Lipid emulsion combined with epinephrine and vasopressin does not improve survival in a swine model of bupivacaine-induced cardiac arrest.

Authors:  Shawn D Hicks; David D Salcido; Eric S Logue; Brian P Suffoletto; Philip E Empey; Samuel M Poloyac; Donald R Miller; Clifton W Callaway; James J Menegazzi
Journal:  Anesthesiology       Date:  2009-07       Impact factor: 7.892

3.  Increasing CPR duration prior to first defibrillation does not improve return of spontaneous circulation or survival in a swine model of prolonged ventricular fibrillation.

Authors:  Jon C Rittenberger; Brian Suffoletto; David Salcido; Eric Logue; James J Menegazzi
Journal:  Resuscitation       Date:  2008-07-11       Impact factor: 5.262

4.  Vasopressin treatment of verapamil toxicity in the porcine model.

Authors:  J Dave Barry; Dave Durkovich; Lee Cantrell; William Richardson; Tri Tong; Steve Offerman; Richard F Clark; David A Tanen; Saralyn Williams
Journal:  J Med Toxicol       Date:  2005-12

Review 5.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

6.  Effect of vasopressin on hippocampal injury in a rodent model of asphyxial cardiopulmonary arrest.

Authors:  Nan Zhang; Xiu-Xian Zang; Ning Dong; Fang Liu; Shao-Kun Wang; H E Yan; DA-Hai Xu; Xiao-Liang Liu; L I Pang
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

Review 7.  Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.

Authors:  Andrea Pasquale Cossu; Paolo Mura; Lorenzo Matteo De Giudici; Daniela Puddu; Laura Pasin; Maurizio Evangelista; Theodoros Xanthos; Mario Musu; Gabriele Finco
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

8.  Vasopressin improves survival in a porcine model of abdominal vascular injury.

Authors:  Karl H Stadlbauer; Horst G Wagner-Berger; Anette C Krismer; Wolfgang G Voelckel; Alfred Konigsrainer; Karl H Lindner; Volker Wenzel
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Vasopressin and epinephrine in the treatment of cardiac arrest: an experimental study.

Authors:  Konstantinos Stroumpoulis; Theodoros Xanthos; Georgios Rokas; Vassiliki Kitsou; Dimitrios Papadimitriou; Ioannis Serpetinis; Despina Perrea; Lila Papadimitriou; Evangelia Kouskouni
Journal:  Crit Care       Date:  2008-03-14       Impact factor: 9.097

10.  Vasopressin decreases neuronal apoptosis during cardiopulmonary resuscitation.

Authors:  Chi Ma; Zhe Zhu; Xu Wang; Gang Zhao; Xiaoliang Liu; Rui Li
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.